Wedbush sets a new price target for Idenix Pharmaceuticals (IDIX +4.3%) of $24 on renewed...

Wedbush sets a new price target for Idenix Pharmaceuticals (IDIX+4.3%) of $24 on renewed speculation that a Big Pharma player may take an interest in buying the company. Potential suitors: MRK, JNJ, ABT.